Study to rescue Strensiq's power in hypophosphatasia patients
NCT ID NCT06015750
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 17 times
Summary
This study aimed to see if adding immunosuppressive therapy could help people with hypophosphatasia who stopped responding to the drug Strensiq due to their immune system. The study was withdrawn before enrolling any participants. It focused on patients who had antibodies against Strensiq and showed worsening symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPHOSPHATASIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.